NCT06597916 - RSV Vaccination in Immunocompromised Patients. | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

March 31, 2026

Conditions

RSV Infection

Interventions

BIOLOGICAL

Arexvy powder and suspension for injection

Arexvy powder and suspension for injection (RSV vaccine)

Trial Locations (1)

RECRUITING

Institute of Specific Prophylaxis and Tropical Medicine, CePII, Medical university of Vienna, Vienna